TFRC and neoplasm: Though some preceding researches have mentioned that the reduction of FECH activity in tumor cells and the increase of transferrin receptor activity in heme biosynthesis account for the phenomenon (20), recent studies have been unable to figure out the connection between PpIX levels in tumor cells and the expression of FECH or any other specific enzymes in heme biosynthesis pathway and porphyrin transporters (21–23).